1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2017The Kiplinger Washington Editors
These biotechnology companies are making important strides in treating many forms of cancer.
Todd Sullivan has no formal training, but his posts are always illuminating.
My picks are risky, but the opportunities are great.
More Investing News »